Kraematon Investment Advisors »

Ocular Therapeutix shares owned by Kraematon Investment Advisors

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Kraematon Investment Advisors from 13F filings

Historical chart of Kraematon Investment Advisors investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Kraematon Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Kraematon Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $827k 98k 8.47

More positions owned by Kraematon Investment Advisors

Raytheon Technologies Corp (RTX)
World Gold Tr Spdr Gld Minis (GLDM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vaneck Fds Emerging Markets (EMBX)
First Tr Exchange-traded SHS (FVD)
Ishares Tr Faln Angls Usd (FALN)
Invesco Exch Traded Fd Tr Ii S&p Intl Momnt (IDMO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
IDEXX Laboratories (IDXX)
Casella Waste Sys Cl A (CWST)
Sun Life Financial (SLF)
Pembina Pipeline Corp (PBA)
Amphenol Corp Cl A (APH)
Vaneck Etf Trust Gold Miners Etf (GDX)

View all positions for Kraematon Investment Advisors

Top funds holding Ocular Therapeutix

FMR
Deep Track Capital
BlackRock
Summer Road
Vanguard Group
venBio Select Advisor
VR Adviser
Vanguard Capital Management
Point72 Asset Management
Adage Capital Partners GP
Geode Capital Management
State Street Corporation
Alliancebernstein
Logos Global Management
Octagon Capital Advisors

View all funds holding Ocular Therapeutix